Aventure AB
Lund, 223 63, Sweden
NCT Number: NCT04848233
The specific goal of this pilot study is to evaluate if it is possible to detect a statistical difference in postprandial glycemia after meals served with and without a drink previously shown to reduce postprandial glycemia by about 25%. A third drink, with a new recipe, is also included for comparisons. Six participants will carry continuous blood glucose monitors for 10 days and follow a specific meal schedule. The data from this study will form the basis for forming hypothesis of future studies as well as make appropriate calculations of statistical power.
Looking for future studies?
Notify Me40 year–65 year
All sexes
Interventional
Not applicable
Lund, 223 63, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Same diet will be repeated for 3 days in a row and the beverage switched every day. 3 periods of 3 days are included in the study.
Time frame: From start of meal (0 min) to 120 min postprandially
Incremental area under the blood glucose curve after each meal
Time frame: 24 hour cycles
Variation in blood glucose levels
DoubleGood AB
Industry
Development of Methodology for Use of Continuous Blood Glucose Measurements When Evaluating Meal Effects on Glucose Regulation - a Pilot Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686939
Glucose Metabolism Disorders, Glycemic Control
Taizhou, Zhejiang, China
View Trial DetailsNCT07513961
Diabetes Mellitus, Diabetes Mellitus, Type 2
Alanya, Antalya, Turkey (Türkiye)
View Trial DetailsNCT07037212
Diabetes Mellitus, Diabetes Mellitus, Type 2
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04332393
Corticosteroids Induced Hyperglycemia, Glycemic Control
Tiberias, North, Israel
View Trial Details